Trials / Completed
CompletedNCT04267614
This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.
Clinical Outcomes of Early Versus Delayed Management of Iraqi Patients With Rheumatoid Arthritis With Etanercept
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,226 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 0 Years
- Healthy volunteers
- Not accepted
Summary
This study is to investigate the effect of etanercept in early versus delayed referral for management of rheumatoid arthritis patients assessing real-world patient data entered in the Iraq National Center of Rheumatology database between May 2012 and May 2017.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etanercept | Patients who received etanercept for RA |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2020-02-13
- Last updated
- 2023-07-07
- Results posted
- 2023-07-07
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT04267614. Inclusion in this directory is not an endorsement.